Omega-3 (EPA/DHA)
Essential polyunsaturated fatty acids critical for brain function, cardiovascular health, and systemic inflammation resolution. Among the most evidence-backed supplements for multiple systems.
What is Omega-3 (EPA/DHA)?
Omega-3 fatty acids are a family of essential polyunsaturated fatty acids (PUFAs) that the human body cannot synthesize de novo. EPA and DHA are the biologically active long-chain forms found primarily in marine sources, while ALA is the plant-derived precursor with limited conversion efficiency.
Known Health Benefits
How It Works
EPA and DHA are incorporated into cell membrane phospholipids, altering membrane fluidity and lipid raft composition, which modulates receptor signaling. EPA is the preferred substrate for cyclooxygenase and lipoxygenase enzymes, producing series-3 prostaglandins and series-5 leukotrienes that are significantly less inflammatory than their omega-6-derived counterparts. EPA and DHA also give rise to specialized pro-resolving mediators (SPMs) — resolvins, protectins, and maresins — that actively resolve inflammation rather than merely suppressing it. In cardiovascular tissue, omega-3s reduce hepatic VLDL and triglyceride synthesis, improve endothelial function via nitric oxide upregulation, and stabilize cardiac ion channels (particularly sodium and L-type calcium channels), reducing arrhythmia risk. DHA constitutes approximately 40% of polyunsaturated fatty acids in brain gray matter and 60% in retinal photoreceptors, where it maintains synaptic membrane fluidity and supports neurotransmission. Omega-3s also modulate gene expression through PPARs and NF-κB, reducing pro-inflammatory cytokine production.
What Research Says
The REDUCE-IT trial (Bhatt et al., NEJM 2019) demonstrated that high-dose icosapent ethyl (4 g/day purified EPA) reduced major adverse cardiovascular events by 25% in statin-treated patients with elevated triglycerides. A meta-analysis by Grosso et al. (Journal of Affective Disorders, 2014) of 19 RCTs found EPA-predominant formulations significantly reduced depressive symptoms. The Cochrane review by Abdelhamid et al. (2020) of 86 RCTs found modest cardiovascular mortality reduction with long-chain omega-3 supplementation. The VITAL trial (Manson et al., NEJM 2019) showed a significant 28% reduction in heart attacks with 1 g/day omega-3 supplementation. For triglycerides, a meta-analysis by Skulas-Ray et al. (Circulation, 2019) confirmed dose-dependent reductions of 20–30% with 2–4 g/day EPA+DHA. Brain imaging studies demonstrate higher omega-3 index correlates with larger hippocampal volumes and reduced brain aging.
Active Compounds
Eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA)
Forms & Bioavailability
Re-esterified triglyceride and phospholipid (krill) forms show 50–70% greater absorption than ethyl esters. Taking omega-3s with a fat-containing meal increases absorption by 3-fold compared to fasting.
Dosage Guidance
| Use Case | Dosage |
|---|---|
| General health | 1000 mg EPA+DHA/day |
| Depression/mood support | 1000–2000 mg EPA/day |
| Triglyceride reduction | 2000–4000 mg EPA+DHA/day |
| Anti-inflammatory | 2000–3000 mg EPA+DHA/day |
| Pregnancy/brain development | 300–600 mg DHA/day |
Always consult a healthcare provider for personalized dosing.
Natural Food Sources
- Wild salmon and sockeye salmon
- Sardines and anchovies
- Mackerel
- Herring
- Oysters
- Algae (vegan DHA source)
- Chia seeds and walnuts (ALA only)
Potential Side Effects
Fishy aftertaste, GI upset; may increase bleeding risk at high doses (>3g/day)
Who Should Avoid It
- Known fish or shellfish allergy (use algal oil)
- Active bleeding disorders
- Scheduled surgery (discontinue 1–2 weeks before)
- Aspirin-sensitive asthma (rare exacerbation reported)
Pregnancy & Lactation
DHA is critical for fetal brain and retinal development, particularly in the third trimester. The American Pregnancy Association recommends at least 300 mg DHA daily. Most prenatal vitamins contain insufficient DHA. Low-mercury sources (algal oil, purified fish oil) are preferred. EPA+DHA supplementation during pregnancy is associated with reduced preterm birth risk.
Known Drug Interactions
May enhance effects of blood thinners; interacts with blood pressure medications
Evidence Classification
Supported by randomized controlled trials (RCTs), systematic reviews, or meta-analyses published in peer-reviewed journals.
Frequently Asked Questions
What is the optimal EPA to DHA ratio?
It depends on the goal. For depression and inflammation, EPA-predominant formulas (≥60% EPA) are more effective. For brain health and cognitive support, DHA-predominant formulas are preferred. For general cardiovascular health, a balanced ratio works well.
How do I choose between fish oil and krill oil?
Krill oil provides omega-3s in phospholipid form with better brain bioavailability and includes astaxanthin, but at lower total EPA/DHA per capsule. Fish oil is more economical for high-dose therapeutic use. Both are effective for general health.
Can vegans get enough omega-3?
Algal oil supplements provide DHA and some EPA directly from microalgae, the original source in the marine food chain. ALA from flaxseed and walnuts converts to EPA at only 5–10% and to DHA at 2–5%, making direct supplementation advisable for vegans.
What is the omega-3 index and why does it matter?
The omega-3 index measures EPA+DHA as a percentage of red blood cell membrane fatty acids. An index of 8–12% is associated with the lowest cardiovascular risk. Most Western populations average 4–5%. It takes 3–4 months of supplementation to significantly change the index.
Do omega-3s thin the blood?
At standard doses (1–2 g/day), omega-3s have mild anti-platelet effects but do not significantly increase bleeding risk. At high doses (>3 g/day), they may potentiate anticoagulants. The American Heart Association considers up to 3 g/day safe without medical supervision.
How do I avoid fishy burps from fish oil?
Choose enteric-coated capsules, triglyceride-form oil, or emulsified liquid. Store fish oil in the freezer — frozen capsules dissolve lower in the GI tract. Taking with meals also reduces reflux. High-quality oils with low oxidation (TOTOX) values produce less fishy aftertaste.
References
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia (REDUCE-IT). Bhatt DL, Steg PG, Miller M, et al.. New England Journal of Medicine (2019)View study
- Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis. Grosso G, Pajak A, Marventano S, et al.. Journal of Affective Disorders (2014)View study
- Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Abdelhamid AS, Brown TJ, Brainard JS, et al.. Cochrane Database of Systematic Reviews (2020)View study
- Omega-3 Fatty Acids and Cardiovascular Disease: Summary of the 2019 AHA Science Advisory. Skulas-Ray AC, Wilson PWF, Harris WS, et al.. Circulation (2019)View study
Related Health Conditions
Related Supplements
Have questions about Omega-3 (EPA/DHA)?
Ask Mother Nature AI about dosing, interactions with your medications, whether it fits your health goals, and more — personalized to your health profile.
This entry is for educational purposes only. It is not medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement regimen, especially if you take medications or have health conditions.